Sale!

SLC29A3 Gene Histiocytosis-lymphadenopathy plus syndrome Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SLC29A3 gene histiocytosis-lymphadenopathy plus syndrome genetic test is a specialized diagnostic procedure aimed at identifying mutations in the SLC29A3 gene, which are associated with a rare disorder known as histiocytosis-lymphadenopathy plus syndrome. This condition is characterized by a wide range of symptoms, including, but not limited to, histiocytosis, lymph node enlargement, and potentially other systemic symptoms depending on the individual. The syndrome falls under the umbrella of histiocytic disorders, which involve an abnormal increase of histiocytes, a type of white blood cell, leading to tissue damage and organ dysfunction.

The test is performed at DNA Labs UAE, a facility known for its advanced genetic testing capabilities. By analyzing a patient’s DNA, the test can confirm the presence of mutations in the SLC29A3 gene, providing crucial information for the diagnosis, treatment planning, and management of the condition. This genetic insight not only helps in understanding the patient’s condition better but also assists in predicting the disease course and potential response to treatment.

The cost of the SLC29A3 gene histiocytosis-lymphadenopathy plus syndrome genetic test at DNA Labs UAE is 4400 AED. This investment is valuable for patients seeking a definitive diagnosis for their symptoms, which can often be complex and challenging to understand without a genetic basis. Early and accurate diagnosis through such genetic testing can significantly impact the quality of life and health outcomes for individuals with this rare syndrome.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC29A3 Gene Histiocytosis-lymphadenopathy plus syndrome Genetic Test

Test Name: SLC29A3 Gene Histiocytosis-lymphadenopathy plus syndrome Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SLC29A3 Gene Histiocytosis-lymphadenopathy plus syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC29A3 Gene Histiocytosis-lymphadenopathy plus syndrome NGS Genetic DNA Test gene SLC29A3

Test Details

SLC29A3 gene histiocytosis-lymphadenopathy plus syndrome is a rare genetic disorder characterized by lymphadenopathy (enlarged lymph nodes) and histiocytosis (abnormal accumulation of immune cells called histiocytes). This condition is caused by mutations in the SLC29A3 gene, which provides instructions for producing a protein involved in the transport of certain molecules across cell membranes.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of SLC29A3 gene histiocytosis-lymphadenopathy plus syndrome, NGS genetic testing can be used to identify mutations in the SLC29A3 gene. This test can help confirm a diagnosis, provide information about the specific genetic variant causing the condition, and assist in genetic counseling for affected individuals and their families.

NGS genetic testing involves obtaining a DNA sample, typically through a blood or saliva sample, and sequencing the DNA to identify any genetic variations or mutations. The results of the test can help healthcare professionals better understand the underlying cause of the condition and guide treatment decisions.

It is important to note that genetic testing for SLC29A3 gene histiocytosis-lymphadenopathy plus syndrome may not be readily available in all healthcare settings. A geneticist or genetic counselor can provide more information on the availability and appropriateness of this test for an individual’s specific situation.

Test Name SLC29A3 Gene Histiocytosis-lymphadenopathy plus syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC29A3 Gene Histiocytosis-lymphadenopathy plus syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC29A3 Gene Histiocytosis-lymphadenopathy plus syndrome NGS Genetic DNA Test gene SLC29A3
Test Details

SLC29A3 gene histiocytosis-lymphadenopathy plus syndrome is a rare genetic disorder characterized by lymphadenopathy (enlarged lymph nodes) and histiocytosis (abnormal accumulation of immune cells called histiocytes). This condition is caused by mutations in the SLC29A3 gene, which provides instructions for producing a protein involved in the transport of certain molecules across cell membranes.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of SLC29A3 gene histiocytosis-lymphadenopathy plus syndrome, NGS genetic testing can be used to identify mutations in the SLC29A3 gene. This test can help confirm a diagnosis, provide information about the specific genetic variant causing the condition, and assist in genetic counseling for affected individuals and their families.

NGS genetic testing involves obtaining a DNA sample, typically through a blood or saliva sample, and sequencing the DNA to identify any genetic variations or mutations. The results of the test can help healthcare professionals better understand the underlying cause of the condition and guide treatment decisions.

It is important to note that genetic testing for SLC29A3 gene histiocytosis-lymphadenopathy plus syndrome may not be readily available in all healthcare settings. A geneticist or genetic counselor can provide more information on the availability and appropriateness of this test for an individual’s specific situation.